| Product NDC: | 14290-378 |
| Proprietary Name: | Tretin-X |
| Non Proprietary Name: | tretinoin |
| Active Ingredient(s): | .25 mg/g & nbsp; tretinoin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 14290-378 |
| Labeler Name: | Triax Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075529 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100801 |
| Package NDC: | 14290-378-02 |
| Package Description: | 2 g in 1 TUBE (14290-378-02) |
| NDC Code | 14290-378-02 |
| Proprietary Name | Tretin-X |
| Package Description | 2 g in 1 TUBE (14290-378-02) |
| Product NDC | 14290-378 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tretinoin |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20100801 |
| Marketing Category Name | ANDA |
| Labeler Name | Triax Pharmaceuticals, LLC |
| Substance Name | TRETINOIN |
| Strength Number | .25 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |